Aziyo Biologics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Aziyo Biologics, Inc. | AZYO - NASDAQ |
$16.00-$18.00 | $17.00 | $17.32 | 2.9 million | 10/8/2020 |
| Piper Sandler, Cowen | ||||||
Co-Manager(s): Cantor, Truist Securities | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-09-14 Terms Added 2020-09-30 | ||||||
Aziyo Biologics, Inc. Quote & Chart - Click for current quote - AZYO
IPO Boutique aggregates information on public companies and private companies, such as "AZYO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Aziyo Biologics, Inc. (adapted from Aziyo Biologics, Inc. prospectus):
They are a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AZYO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.